Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | TOP1 | P11387 | 3/20 | 0.34 |
| ▸ | COMT | P21964 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.33 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.33 |
| ▸ | PPARG | P37231 | 4/20 | 0.33 |
| ▸ | PPARA | Q07869 | 2/20 | 0.33 |
| ▸ | AKT1 | P31749 | 2/20 | 0.32 |
| ▸ | AKT2 | P31751 | 1/20 | 0.32 |
| ▸ | AKT3 | Q9Y243 | 1/20 | 0.32 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | KIF11 | P52732 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL261528 | 0.96 | KDM4E (0.41) | L3MBTL1KDM4EATMCOMTALDH1A1 | |
| SCHEMBL15695210 | 0.94 | KDM4E (0.43) | L3MBTL1KDM4EATMCOMTALDH1A1 | |
| SCHEMBL261831 | 0.89 | KDM4E (0.47) | L3MBTL1KDM4EATMCOMTALDH1A1 | |
| SCHEMBL13141973 | 0.89 | KDM4E (0.47) | L3MBTL1KDM4EATMCOMTALDH1A1 | |
| SCHEMBL16769710 | 0.87 | L3MBTL1 (0.34) | L3MBTL1KDM4EATMCOMTNPC1 | |
| SCHEMBL12383130 | 0.87 | KIF11 (0.38) | TOP1MAPK14KIF11 | |
| SCHEMBL13811428 | 0.86 | MAOA (0.39) | L3MBTL1KDM4EATMCOMTALDH1A1 | |
| SCHEMBL17425807 | 0.85 | HTT (0.33) | L3MBTL1KDM4EATMCOMTALDH1A1 | |
| SCHEMBL16482263 | 0.84 | L3MBTL1 (0.43) | L3MBTL1KDM4EATMTOP1COMT | |
| SCHEMBL16482566 | 0.84 | KDM4E (0.53) | L3MBTL1KDM4EATMALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9484541-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2016-11-01 | — | — | US | disclosed |
| US-9484541-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2016-11-01 | — | — | US | disclosed |
| US-20160111661-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2016-04-21 | — | — | US | disclosed |
| US-20160111661-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2016-04-21 | — | — | US | disclosed |
| US-20160104848-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2016-04-14 | — | — | US | disclosed |
| US-20160104848-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2016-04-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160111661-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | MLX, ZYX, LBR | L3MBTL1 81/4885KDM4E 1495/4885ATM 3332/4885 |
| US-20160104848-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | ORC3, FARS2, FARSA | L3MBTL1 1216/4885KDM4E 3162/4885ATM 3925/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.